Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Blood

• Publication date

  1994-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V83.4.1060.BLOODJOURNAL8341060PMID 8111046
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance

  2004cited by this paper
• Adhesion molecules on freshly recovered T leukemias promote tumor-directed lympholysis.

  1992cited by this paper
• Induction of CD11a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibility to T-cell but not lymphokine-activated killer-cell cytotoxicity.

  1992cited by this paper
• Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes

  1991cited by this paper
• Minor histocompatibility antigens, defined by graft‐vs.‐host disease‐derived cytotoxic T lymphocytes, show variable expression on human skin cells

  1991cited by this paper
• EFFECTOR MECHANISMS IN GRAFT‐VERSUS-HOST DISEASE IN RESPONSE TO MINOR HISTOCOMPATIBILITY ANTIGENS: I. ABSENCE OF CORRELATION WITH CYTOTOXIC EFFECTOR CELLS

  1990cited by this paper
• Graft-versus-leukemia reactions after bone marrow transplantation.

  1990cited by this paper
• Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens.

  1990cited by this paper
• Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia.

  1989cited by this paper
• Susceptibility of human male keratinocytes to MHC-restricted H-Y- specific lysis

  1989cited by this paper
• SUSCEPTIBILITY OF HUMAN MALE KERATINOCYTES TO

  1989cited by this paper
• Minor Histocompatibility antigens in man and their role in transplantation.

  1988cited by this paper
• Minor histocompatibility antigen H-Y is expressed on human hematopoietic progenitor cells.

  1988cited by this paper
• Cellularly defined minor histocompatibility antigens are differentially expressed on human hematopoietic progenitor cells

  1988cited by this paper
• Detection of anti-non-MHC-directed T cell reactivity following in vivo priming after HLA-identical marrow transplantation and following in vitro priming in limiting dilution cultures.

  1987cited by this paper
• A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease

  1983cited by this paper
• Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation.

  1981cited by this paper
• Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.

  1979cited by this paper

• Cellular and immunotherapies for myelodysplastic syndromes.

  2024cites this paper
• Unrelated female-to-male bone marrow transplantation would be preferred over cord blood transplantation in male patients.

  2023cites this paper
• Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML

  2023cites this paper
• DNA and modified vaccinia Ankara prime–boost vaccination generates strong CD8+ T cell responses against minor histocompatibility antigen HA‐1

  2021cites this paper
• Identification of a lymphocyte minor histocompatibility antigen in Mauritian cynomolgus macaques

  2020cites this paper
• Minor Histocompatibility Antigen-Specific T Cells

  2020cites this paper
• Identifying a Minor Histocompatibility Antigen in Mauritian Cynomolgus Macaques Encoded by APOBEC3C

  2020cites this paper
• The Graft-Versus-Leukemia Effect in AML

  2019cites this paper
• Development of T-cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse.

  2018cites this paper
• Biology of the Human Graft‐versus‐Tumor Response and How to Exploit It

  2016cites this paper
• Predicted Indirectly ReCognizable HLA Epitopes Class I Promote Antileukemia Responses after Cord Blood Transplantation: Indications for a Potential Novel Donor Selection Tool.

  2016cites this paper
• Possible Role of Minor H Antigens in the Persistence of Donor Chimerism after Stem Cell Transplantation; Relevance for Sustained Leukemia Remission

  2015cites this paper
• Minor histocompatibility antigens: past, present, and future.

  2014cites this paper
• potent primary in vitro induction memory T cells: artificial APCs pave the way for clinical application by specific CD8+ effector - Cytotoxic minor histocompatibility antigen HA-1

  2013cites this paper
• Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.

  2013influential citation
• relapsed leukemia after HLA-mismatched stem cell transplantation T cells restricted by nonself HLA molecules: a potential strategy to treat specific cytotoxic - Generation of minor histocompatibility antigen HA-1

  2013cites this paper
• System-Restricted Minor Histocompatibility Antigens Generated Cytotoxic T Lymphocytes Specific for Hematopoietic - Feasibility of Immunotherapy of Relapsed Leukemia With Ex Vivo

  2013cites this paper
• Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation

  2012cites this paper
• Minor H antigens in GVHD and GVL Multi-center analyses demonstrate significant clinical effects of minor Histocompatibility antigens on GVHD and GVL after HLA matched related and unrelated stem-cell transplant Manuscript submitted for publication

  2012cites this paper
• El papel de la genética de poblaciones en la inmunología del trasplante en México

  2012cites this paper
• Minor histocompatibility antigen typing by DNA sequencing for clinical practice in hematopoietic stem-cell transplantation.

  2012cites this paper
• [The role of population genetics of Mexico in transplant immunology].

  2012cites this paper
• Factors affecting the induction of transplantation tolerance in bone marrow transplantation

  2012cites this paper
• Targeting the mismatched minor antigen HA-1 may boost the conversion to complete donor chimerism by eradicating host hematopoietic stem/progenitor cells

  2012cites this paper
• Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia

  2011cites this paper
• Dimerization of Soluble Disulfide Trap Single-Chain Major Histocompatibility Complex Class I Molecules Dependent on Peptide Binding Affinity

  2011cites this paper
• An anti-PR1/HLA-A2 T-cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells.

  2011cites this paper
• Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantation

  2010cites this paper
• marrow transplantation for chronic myelogenous leukemia graft-versus- leukemia reactivity after T-cell-depleted allogeneic Use of unrelated marrow grafts compensates for reduced

  2010cites this paper
• Fetal microchimerism and cancer.

  2009cites this paper
• Donor Lymphocyte Infusions Clinical Applications and the Graft‐versus‐Leukemia Effect

  2008cites this paper
• Donor lymphocyte infusions for acute myeloid leukaemia.

  2008cites this paper
• Eine neue Strategie zur Identifikation von minor H-Antigenen

  2008cites this paper
• Eine neue Strategie zur Identifikation von minor H-Antigenen

  2008cites this paper
• Targeting haematopoietic-specific minor histocompatibility antigens to distinguish graft-versus-tumour effects from graft-versus-host disease.

  2008cites this paper
• Vaccination with HA-1 peptide in patients showing minimal residual disease or mixed chimerism after allogeneic stem cell transplantation and donor lymphocyte infusion

  2008cites this paper
• TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytes.

  2007cites this paper
• Characterization of leukemia - associated minor histocompatibility antigens as targets in anti-leukemic immunotherapy.

  2007cites this paper
• Novel strategies for identification and therapeutic application of minor histocompatibility antigens

  2007cites this paper
• receiving allogeneic bone marrow transplants mice dissociated graft-versus-host and graft-versus-leukemia responses in Crucial role of timing of donor lymphocyte infusion in generating

  2007cites this paper
• Promiscuity of the AlloHLA-A2 restricted T cell repertoire hampers the generation of minor Histocompatibility antigen-specific cytotoxic T cells across HLA barriers.

  2007cites this paper
• Phenotype Frequencies of Autosomal Minor Histocompatibility Antigens Display Significant Differences among Populations

  2007cites this paper
• Can graft-versus-leukemia reactivity be dissociated from graft-versus-host disease?

  2007cites this paper
• Risk assessment in haematopoietic stem cell transplantation: minor histocompatibility antigens.

  2007cites this paper
• The human minor histocompatibility antigen HA-1 : its processing, presentation and recognition

  2006cites this paper
• Proliferation-based T-cell selection for immunotherapy and graft-versus-host-disease prophylaxis in the context of bone marrow transplantation

  2006cites this paper
• Chromosomal aberrations in leukaemia cells may delete tumour target antigens of stem cell-based immunotherapy

  2006cites this paper
• Vaccination for leukemia.

  2006cites this paper
• Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells.

  2005cites this paper
• ALLOGENEIC IMMUNOTHERAPY : THE GRAFT-VERSUS-LEUKEMIA

  2005cites this paper
• Peptide Vaccination of Myeloid Leukemia

  2005cites this paper
• Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia.

  2005cites this paper
• Expanding the immunotherapeutic potential of minor histocompatibility antigens.

  2005cites this paper
• Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction.

  2005cites this paper
• Low-intensity allogeneic hematopoietic stem cell transplantation for myeloid malignancies: separating graft-versus-leukemia effects from graft-versus-host disease

  2005cites this paper
• Adult and cord blood T cells can acquire HA-1 specificity through HA-1 T-cell receptor gene transfer.

  2005cites this paper
• Donor leukocyte infusions and graft‐versus‐malignancy

  2005cites this paper
• Vaccines in leukemia.

  2004cites this paper
• Minor Histocompatibility Antigens: Molecular Barriers for Successful Tissue Transplantation

  2004cites this paper
• Nonmyeloablative allogeneic immunotherapy for solid tumors.

  2004cites this paper
• Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytes.

  2004cites this paper
• Donor lymphocyte infusions.

  2004cites this paper
• Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells

  2004cites this paper
• Hematopoietic Lineage-Restricted Minor Histocompatibility Antigen HA-1 in Graft-Versus-Leukemia Activity After Donor Lymphocyte Infusion

  2004cites this paper
• Quantification of the HA-1 gene product at the RNA level; relevance for immunotherapy of hematological malignancies.

  2003cites this paper
• HLA‐DRB1*16‐restricted recognition of myeloid cells, including CD34+ CML progenitor cells

  2003cites this paper
• Antigens shared by malignant plasma cells and normal B cells may be involved in graft versus myeloma

  2003cites this paper
• Optimizing immunity against BCR-ABL positive leukemia

  2003cites this paper
• Immunotherapy of hematologic malignancy.

  2003cites this paper
• Nonmyeloablative therapy and allogeneic hematopoietic stem cell transplantation.

  2003influential citation
• Identification of minor histocompatibility antigens

  2003cites this paper
• Targeting Alloreactive Donor T-Cells to Hematopoietic System-Restricted Minor Histocompatibility Antigens to Dissect Graft-versus-Leukemia Effects from Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation

  2003cites this paper
• Adoptive Immunotherapy in Chimeras with Donor Lymphocytes

  2003cites this paper
• Platelet antigens. The role of human platelet alloantigens (HPA) in blood transfusion and transplantation.

  2002cites this paper
• Efficient induction of minor histocompatibility antigen HA-1-specific cytotoxic T-cells using dendritic cells retrovirally transduced with HA-1-coding cDNA.

  2002cites this paper
• Graft versus Leukemia and Graft versus Tumor Activity

  2002cites this paper
• Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplants.

  2002cites this paper
• Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation

  2002cites this paper
• CD4(+) bias in T cells cloned from a CML patient with active graft versus leukemia effect.

  2002cites this paper
• Hematopoietic system-specific antigens as targets for cellular immunotherapy of hematological malignancies.

  2002cites this paper
• The Hematopoietic System–specific Minor Histocompatibility Antigen HA-1 Shows Aberrant Expression in Epithelial Cancer Cells

  2002cites this paper
• Induction of HA‐1‐specific cytotoxic T‐cell clones parallels the therapeutic effect of donor lymphocyte infusion

  2002cites this paper
• Minor histocompatibility antigens-targets of graft versus leukemia responses

  2002cites this paper
• Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation.

  2002cites this paper
• The basis of T-cell-mediated immunity to chronic myelogenous leukemia

  2002cites this paper
• Clinical relevance of the minor histocompatibility antigen HA-1 in allogeneic bone marrow transplantation between HLA identical siblings.

  2001cites this paper
• Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation

  2001cites this paper
• Non-myeloablative transplants for malignant disease.

  2001cites this paper
• Umbilical cord blood for allogeneic transplantation in children and adults

  2001cites this paper
• The current status of T-cell depleted allogeneic stem-cell transplants in adult patients with AML.

  2001cites this paper
• Developmental approaches in immunological control of acute myelogenous leukaemia.

  2001cites this paper
• Nonmyeloablative blood stem cell transplantation as adoptive allogeneic immunotherapy for metastatic renal cell carcinoma.

  2001cites this paper
• Application of T cell immunotherapy for human viral and malignant diseases.

  2000cites this paper
• Innovative approaches for allogeneic blood and marrow transplantation for treatment of hematological malignancies: Graft engineering and nonmyeloablative preparative regimens

  2000cites this paper
• Immunotherapy of human viral and malignant diseases with genetically modified T-cell clones.

  2000cites this paper
• Tissue-Specific Antigens in GVL

  2000cites this paper
• Experimental Animal Models in the Study of GVL Reactions

  2000cites this paper
• HLA class I-minor histocompatibility antigen tetramers select cytotoxic T cells with high avidity to the natural ligand.

  2000cites this paper
• T-Cell Subsets and Separation of GVL from GVHD

  2000cites this paper
• Mechanisms of Cure of Acute Myeloid Leukemia with Allogeneic Transplantation

  2000cites this paper